Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire.
about
Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA virusesPathogenesis of human immunodeficiency virus infectionActive human immunodeficiency virus protease is required for viral infectivityResumption of virus production after human immunodeficiency virus infection of T lymphocytes in the presence of azidothymidineProduction of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular cloneThe implications of HIV for the anaesthetist and the intensivist.Human immunodeficiency virus type 1 cellular host range, replication, and cytopathicity are linked to the envelope region of the viral genomeAn Epstein-Barr virus immediate-early gene product trans-activates gene expression from the human immunodeficiency virus long terminal repeat.Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides.Infection of rabbit T-cell and macrophage lines with human immunodeficiency virus.Human immunodeficiency virus type 1 nucleocapsid protein can prevent self-priming of minus-strand strong stop DNA by promoting the annealing of short oligonucleotides to hairpin sequences.Cross-linking of the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase to template-primerInduction of anti-HIV neutralizing antibodies by synthetic peptides.Structural characterization of reverse transcriptase and endonuclease polypeptides of the acquired immunodeficiency syndrome retrovirus.Induction of humoral and cell-mediated anti-human immunodeficiency virus (HIV) responses in HIV sero-negative volunteers by immunization with recombinant gp160.Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1.Selection of RNA aptamers that bind HIV-1 LTR DNA duplexes: strand invaders.Humoral immune responses to T cell tropic retrovirus simian T lymphotropic virus type III in monkeys with experimentally induced acquired immune deficiency-like syndromeThe avian retrovirus env gene family: molecular analysis of host range and antigenic variantsMonoclonal anti-idiotypic antibody mimics the CD4 receptor and binds human immunodeficiency virus.Gag regulates association of human immunodeficiency virus type 1 envelope with detergent-resistant membranes.Selective transmission of R5 HIV-1 variants: where is the gatekeeper?Some human immunodeficiency virus type 1 Vpu proteins are able to antagonize macaque BST-2 in vitro and in vivo: Vpu-negative simian-human immunodeficiency viruses are attenuated in vivo.Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA.Identification of conserved and divergent domains within the envelope gene of the acquired immunodeficiency syndrome retrovirus.An anti-CD45RO immunotoxin eliminates T cells latently infected with HIV-1 in vitroGenetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African originThe highly conserved aspartic acid residue between hypervariable regions 1 and 2 of human immunodeficiency virus type 1 gp120 is important for early stages of virus replication.Single amino acid substitution in constant region 1 or 4 of gp120 causes the phenotype of a human immunodeficiency virus type 1 variant with mutations in hypervariable regions 1 and 2 to revertCombined use of an immunotoxin and cyclosporine to prevent both activated and quiescent peripheral blood T cells from producing type 1 human immunodeficiency virus.Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus.Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytesOrgan-specific selection of viral variants during chronic infectionInfection of rabbits with human immunodeficiency virus 1. A small animal model for acquired immunodeficiency syndrome.Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibodyAdeno-associated virus Rep protein inhibits human immunodeficiency virus type 1 production in human cells.Genetic recombination of human immunodeficiency virus.A mutant of human immunodeficiency virus with reduced RNA packaging and abnormal particle morphology.In vivo selection of lymphocyte-tropic and macrophage-tropic variants of lymphocytic choriomeningitis virus during persistent infection.
P2860
Q24627466-EF8A0F99-8DE5-4A94-8218-46BCF054B8CEQ24634681-0F3AF55C-9D00-4A35-A2A2-26D3C008D305Q24647696-1F547511-AA50-4F1B-952F-F946079DAE7CQ28338459-8D47819E-C786-40B5-AE92-17AABA0E598BQ29547734-F7091136-8146-4612-823E-DFAE1C8E6550Q30326734-518B82F8-4BD9-4CC0-8472-AF2722562BE8Q33407962-E15E90E8-A89C-45DA-9948-014B8E029418Q33558271-07BF022D-F15A-4D1E-9BEE-A1FDB15EA5DAQ33560772-86BD4EEF-72F5-4BF2-955C-1E6DE6CA9729Q33582527-72C5C763-8B1A-413B-A282-9577F3BDD647Q33603932-E9A3A0BC-CED3-4F6E-A877-946D1C01C109Q33845922-026EEF93-BD23-427E-B7F0-8AE724175C24Q33880796-A68EB3AC-2051-49AC-BB94-CF01900228E2Q33929366-0E3EA02A-A585-4DF6-AB99-986B4A215511Q34171623-C7858E74-D142-44F6-828C-6C35E4114685Q34292765-FBB88D5D-7457-49A4-8884-2C1806059256Q34401400-E27F91C1-94ED-422B-A43B-D4437C6D79B2Q34545986-8FA2F0B8-18D1-489A-9700-01DEC40F6899Q34552390-D73E728A-1FFB-4799-A1C8-E59C95BFA25FQ34629036-2ADF95BA-A698-44DF-80D9-9695C47E9F71Q34648092-2E13FE47-CFBA-4722-8B95-A72AF20B5493Q35018140-AD67E1C3-48BC-4F10-9B88-E0329A2C7D55Q35383070-929844B9-E5CB-4607-8A73-BD1312F71238Q35610321-24DDE532-8ECA-4504-BD44-DF86DE538AEFQ35616284-7121ADF8-1050-498B-800B-6B263E969343Q35653299-F7A80FA3-AFA5-4743-ADB4-A4463CC7C829Q35829520-6FE8D061-866B-4AF0-88D6-F43AFFF92DA0Q35830393-25751741-5580-4285-A9CB-A6850509B891Q35853972-E1CBAC59-1D4E-4F18-BA57-DDFFEF6B7819Q36106061-74692F65-D1B6-45C7-890D-44A834044DCCQ36232089-1681FF51-EC31-494C-B276-49C324CCDCE0Q36352167-5739998F-9D59-4299-8599-F96B096EA004Q36354762-CFF3C1E7-D12A-42AA-8451-145AB2A49454Q36354968-6C3FB61F-4C0B-4170-A5C0-9070D940E362Q36355901-10A3C416-3723-4CD8-BF93-EC8699DA9A01Q36687562-E29470AE-0F4B-4004-A0F7-0D47CB0A375DQ36688082-1A443540-DD44-4EAD-B1A2-B048FD66E76FQ36782092-7D8DA1C4-DCF9-417A-A526-94F13D77E3BFQ36784524-27694A36-4C98-47FC-BC41-1FE4EF6C03F9Q36793505-5228C83D-050C-49BD-82E7-CBE01BBD370E
P2860
Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire.
@en
Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire.
@nl
type
label
Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire.
@en
Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire.
@nl
prefLabel
Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire.
@en
Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire.
@nl
P2093
P356
P1433
P1476
Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire.
@en
P2093
McCormick J
Rutledge R
P304
P356
10.1126/SCIENCE.2997922
P407
P577
1985-11-01T00:00:00Z